Regulatory Filing For FACTIVE Tablets Submitted In Europe

Oscient Pharmaceuticals Corporation's (Nasdaq: OSCI) commercialization partner for FACTIVEŽ (gemifloxacin mesylate) tablets, Menarini Group, a leading European pharmaceutical company based in Italy, has submitted a regulatory filing seeking approval of FACTIVE in Europe.

http://www.medicalnewstoday.com/articles/106839.php